BioSpace News Archive

Oxford Biomedica, a leading gene and cell therapy group, announces that Dr Frank Mathias will officially join Oxford Biomedica as Chief Executive Officer and Board member on Monday, 27th March 2023.

IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced a first-of-its-kind empirical study aimed at addressing veterinary practice capacity constraints.

Mineralys Therapeutics, Inc. (Nasdaq: MLYS) announced today that abstracts featuring lorundrostat clinical data from both Phase 2 and Phase 1 studies have been selected for a moderated poster presentation and poster presentation at the American College of Cardiology’s 72nd Annual Scientific Session together with the World Congress of Cardiology (ACC.23/WCC).

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced the upcoming presentation of new analyses of results from the SOLOIST-WHF Phase 3 outcomes study of its investigational sotagliflozin product at the American College of Cardiology’s 72nd Annual Scientific Session Together With World Heart Federation’s World Congress of Cardiology in New Orleans, Louisiana.

The Diversity Now Protocol by RxE2 provides a pharmacist-centered approach for compliance with Section V, Categories 4 and 5 of the US Food and Drug Administration’s industry guidance (FDA Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials – Guidance for Industry, April 2022).

Olon Group and the Politecnico di Milano, Department of Chemistry, Materials and Chemical Engineering “Giulio Natta,” jointly announce an innovative public-private partnership agreement for a research project on the advanced study of polymorphism and the characterization of the solid state of the molecules of active ingredients.

Delray Medical Center is the first hospital in Florida to treat an Alzheimer’s disease patient using non-invasive focused ultrasound technology as part of a groundbreaking study being conducted in collaboration with Florida Atlantic University’s Institute for Human Health and Disease Intervention (I-Health).

Eurofins Environment Testing Northern California: Wastewater (EWW) and Eurofins Pandemic Prevention Services (EPPS) today launched a droplet digital PCR (ddPCR) assay for the quantitative analysis of SARS-CoV-2 Variant of Concern (VoC) XBB.1.5 in wastewater.

Immunovia will publish its full year 2022 results on February 23, 2023 at 8:30 am CET.

Covalon Technologies Ltd. announced its participation for the first time in the Conference for Neonatology in Las Vegas, Nevada from Wednesday, February 22 to Friday, February 24, 2023.